Can a patient with relapsed B-cell ALL travel to China for CAR-T treatment?

Potential eligibility depends on the leukemia subtype, antigen expression, previous treatments, disease burden, current health, infections, and the specific treatment program available. International patients can submit their medical records for specialist assessment before traveling.

Can CAR-T therapy be followed by a stem cell transplant for relapsed B-ALL?

In selected patients, CAR-T therapy can produce a remission that creates an opportunity for subsequent allogeneic hematopoietic stem cell transplantation. Whether transplantation is appropriate depends on the patient's response, overall condition, donor availability, and treating team's assessment.

How can a Pakistani leukemia patient arrange treatment in China?

The process typically starts with a medical record review, including pathology, bone marrow reports, imaging, previous chemotherapy records, and current laboratory results. ChinaCureLink can coordinate specialist review, hospital matching, treatment planning, travel arrangements, and ongoing communication with the treating team.

top of page

ChinaCurelink
a MedeboundHEALTH Company

FREE CONSULTATION

69% Bone Marrow Tumor Burden: How Dual-Target CAR-T and Stem Cell Transplant Treated Relapsed B-Cell ALL in China for a Pakistani Patient

ChinaCureLink

Thu Sep 10 2026

7 min read

Widget Didn’t Load

Check your internet and refresh this page.

If that doesn’t work, contact us.

bottom of page